Suxiang Chen received his Bachelor's degree in Agriculture in 2010 from South China Agricultural University (SCAU). He then obtained his Master's degree in Biotechnology (Advanced) and a second Master's degree in Technology and Innovation Management from the University of Queensland (UQ) in 2013 and 2014, respectively. Later, he worked in Darui Biotechonology Co. Ltd and Gene Denovo Biotechnology Co. Ltd in Guangzhou, China as a core technician and technical support team member, respectively. Since 2016, he has been pursuing a PhD degree at Murdoch University under the supervision of Assoc. Prof. Rakesh N. Veedu. He also worked in the Centre for Molecular Medicine and Innovative Therapeutics (CMMIT), Murdoch University as a laboratory assistant (2016-2019) and research assistant (2019-2020). His current research focuses include the development of novel RNA-targeting therapies for tackling type 2 diabetes and solid cancers.
Research Keywords & Expertise
cancer theranostics
Biomedical Science
Technology and innovat...
Antisense drug discove...
Nucleic acid therapeut...
Short Biography
Suxiang Chen received his Bachelor's degree in Agriculture in 2010 from South China Agricultural University (SCAU). He then obtained his Master's degree in Biotechnology (Advanced) and a second Master's degree in Technology and Innovation Management from the University of Queensland (UQ) in 2013 and 2014, respectively. Later, he worked in Darui Biotechonology Co. Ltd and Gene Denovo Biotechnology Co. Ltd in Guangzhou, China as a core technician and technical support team member, respectively. Since 2016, he has been pursuing a PhD degree at Murdoch University under the supervision of Assoc. Prof. Rakesh N. Veedu. He also worked in the Centre for Molecular Medicine and Innovative Therapeutics (CMMIT), Murdoch University as a laboratory assistant (2016-2019) and research assistant (2019-2020). His current research focuses include the development of novel RNA-targeting therapies for tackling type 2 diabetes and solid cancers.